Can you explain the results of the IFM 2009 trial?

 

In this week’s video, Dr. Brian G.M. Durie explains the somewhat confusing results of the IFM 2009 trial.

BOTTOM LINE:

With longer follow-up, the IFM 2009 trial may be able to demonstrate longer overall survival of patients in the transplant group.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org